NeuroSense Therapeutics (NRSN) Earnings Date, Estimates & Call Transcripts → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free NRSN Stock Alerts $1.23 -0.06 (-4.65%) (As of 05/8/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateJun. 6EstimatedActual EPS (Apr. 5) -$0.16 Missed By -$0.16 Get NeuroSense Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for NRSN and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueNRSN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NRSN Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. NRSN Earnings Date and InformationNeuroSense Therapeutics last issued its quarterly earnings results on April 5th, 2024. The reported ($0.16) earnings per share (EPS) for the quarter. NeuroSense Therapeutics has generated ($0.83) earnings per share over the last year (($0.83) diluted earnings per share). NeuroSense Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, June 6th, 2024 based off prior year's report dates.Read More NeuroSense Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 6/6/2024Estimated)------- 4/5/2024Q4 2023-($0.16)($0.16)($0.16)--11/28/2023Q3 2023-$0.10+$0.10$0.10--8/16/2023Q2 2023-($0.44)($0.44)($0.44)--6/1/2023Q1 2023-($0.33)($0.33)($0.33)--3/22/2023Q4 2022-($0.27)($0.27)($0.27)--12/1/2022Q3 2022-($0.25)($0.25)($0.25)-- Get the Latest News and Ratings for NRSN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NeuroSense Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/31/2022Q2 2022-($0.31)($0.31)($0.31)--5/31/2022Q1 2022-($0.25)($0.25)($0.25)-- NeuroSense Therapeutics Earnings - Frequently Asked Questions When is NeuroSense Therapeutics's earnings date? NeuroSense Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, June 6th, 2024 based off last year's report dates. Learn more on NRSN's earnings history. How much profit does NeuroSense Therapeutics generate each year? NeuroSense Therapeutics (NASDAQ:NRSN) has a recorded net income of -$11.28 million. NRSN has generated -$0.83 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Indaptus Therapeutics Earnings Galecto Earnings Vincerx Pharma Earnings Avalo Therapeutics Earnings Talphera Earnings KALA BIO Earnings Orgenesis Earnings BioVie Earnings Sol-Gel Technologies Earnings Alaunos Therapeutics Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:NRSN) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithDems have chosen Biden replacement?Paradigm Press348 million Americans lives to END as we know it?The Oxford ClubGold Set to EXPLODE!Gold Safe ExchangeObama’s Forever Term [exposed]Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroSense Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
